Literature DB >> 23756061

Structure-cytotoxic activity relationship of 3-arylideneflavanone and chromanone (E,Z isomers) and 3-arylflavones.

Bogumiła Kupcewicz1, Grażyna Balcerowska-Czerniak, Magdalena Małecka, Piotr Paneth, Urszula Krajewska, Marek Rozalski.   

Abstract

The E,Z-isomers of 3-arylidene substituted flavanone, chromanone and 3-aryl substituted flavone derivatives were tested in vitro for their cytotoxic activity against three cancer cell lines (HL-60, NALM-6, WM-115) and normal cell line (HUVEC). It was observed that substitution at C3 position led to significant enhance in cytotoxicity. Isomeric configuration of 3-arylideneflavanones had an influence on the cytotoxic potential. Multiple regression analysis combined with variable selection by genetic algorithm was used to model relationships between molecular descriptors and the cytotoxic activity. The most accurate QSAR models were based on a combination between energy of LUMO, experimental value of logP and partial charge on carbonyl oxygen (δO2).
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23756061     DOI: 10.1016/j.bmcl.2013.05.044

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.

Authors:  Igor A Schepetkin; Alexander S Karpenko; Andrei I Khlebnikov; Marina O Shibinska; Igor A Levandovskiy; Liliya N Kirpotina; Nadezhda V Danilenko; Mark T Quinn
Journal:  Eur J Med Chem       Date:  2019-09-18       Impact factor: 6.514

2.  Analysis of two novel 1-4 quinolinone structures with bromine and nitrobenzyl ligands.

Authors:  Lidiane J Michelini; Wesley F Vaz; Giulio D C D'Oliveira; Caridad N Pérez; Hamilton B Napolitano
Journal:  J Mol Model       Date:  2019-02-08       Impact factor: 1.810

3.  Interaction of Arylidenechromanone/Flavanone Derivatives with Biological Macromolecules Studied as Human Serum Albumin Binding, Cytotoxic Effect, Biocompatibility Towards Red Blood Cells.

Authors:  Angelika A Adamus-Grabicka; Magdalena Markowicz-Piasecka; Michał B Ponczek; Joachim Kusz; Magdalena Małecka; Urszula Krajewska; Elzbieta Budzisz
Journal:  Molecules       Date:  2018-12-01       Impact factor: 4.411

4.  Crystal structures of (E)-3-(4-hy-droxy-benzyl-idene)chroman-4-one and (E)-3-(3-hy-droxy-benzyl-idene)-2-phenyl-chroman-4-one.

Authors:  Kamil Suchojad; Anna Dołęga; Angelika Adamus-Grabicka; Elżbieta Budzisz; Magdalena Małecka
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2019-11-22

5.  Biological Evaluation of 3-Benzylidenechromanones and Their Spiropyrazolines-Based Analogues.

Authors:  Angelika A Adamus-Grabicka; Magdalena Markowicz-Piasecka; Marcin Cieślak; Karolina Królewska-Golińska; Paweł Hikisz; Joachim Kusz; Magdalena Małecka; Elzbieta Budzisz
Journal:  Molecules       Date:  2020-04-01       Impact factor: 4.411

Review 6.  Chromanone-A Prerogative Therapeutic Scaffold: An Overview.

Authors:  Sonia Kamboj; Randhir Singh
Journal:  Arab J Sci Eng       Date:  2021-06-30       Impact factor: 2.807

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.